Key result
Cannabis edibles linked to a clinically insignificant ~8 bpm drop in heart rate.
Why the study?
Does the consumption of commercially available cannabis edibles acutely alter heart rate in daily and occasional users?
Observational (n=59)
Does the consumption of commercially available cannabis edibles acutely alter heart rate in daily and occasional users?
Unlike inhaled products, commercially available edible cannabis does not appear to produce a robust acute increase in heart rate when used naturalistically.
Acute HR rises with commercial edibles warrant caution in CV patients; leaves open need for controlled dose-response trials.
Introduction: Studies have shown that tetrahydrocannabinol (THC) consumption can acutely increase heart rate (HR) regardless of the percent concentration of the product consumed, mode of consumption (e.g. flower, edibles, concentrate), and tolerance. Prior studies have found that the magnitude of this effect is slightly larger in inhaled products, however few purposeful studies on HR response to commercially available edible cannabis have been done. Materials & Methods Participants (N = 59) were consented and asked to use at least 5mg of cannabis edibles during their study visit. Participants were enrolled into one of two cannabis use categories based on self-reported frequency of their cannabis use. Participants who use any cannabis product daily (defined for study purposes as 29 days of the last 30) and occasionally (participants who use cannabis at least one time per month but no more than three times per week). Venous blood samples were taken at baseline and after edible consumption, from an intravenous line at an average of 43 (post 1), 89 (post 2) and 178 minutes (post 3) post cannabis use. Participants were seated for all HR collection which occurred at baseline and an average of 39 (post 1), 84 (post 2), and 163 (post3) minutes after the participant’s end of cannabis consumption. Medications and medical conditions that suppress HR or induce elevated HR were identified and controlled for in this analysis. Results Overall, we observed a statistically significant but small non-clinically significant decrease in HR after consumption of cannabis edible. This was observed across participants in the occasional and daily groups, and across a range of doses. This decrease was only statistically significant in certain dose groups. This finding is excepted by the 10-20mg edible group at the post 2 timepoint (expected peak drug effect), where we observed a non-clinically significant (~ 5bpm) increase in HR. Discussion This analysis suggests that edible cannabis does not have the same impact on HR as inhaled cannabis products. This analysis also suggests that commercially available edible cannabis does not produce a robust cardiovascular response when used naturalistically.
No takes yet. Share an insight, caveat, or question.
Limbacher et al. (2026) conducted an observational in Healthy cannabis users (n=59). Commercially available cannabis edibles vs. Baseline (pre-consumption) was evaluated on Heart rate at ~40 minutes post-consumption (<10mg dose group) (p=<0.01). Commercially available cannabis edibles produced a small, non-clinically significant decrease in heart rate, such as a reduction from 78.0 to 70.0 bpm in the <10mg dose group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: